Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bausch Health Companies Inc
(NY:
BHC
)
5.990
+0.110 (+1.87%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,184,186
Open
5.920
Bid (Size)
5.400 (2)
Ask (Size)
6.000 (2)
Prev. Close
5.880
Today's Range
5.685 - 6.040
52wk Range
3.960 - 11.46
Shares Outstanding
358,808,755
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BHC Stock Plunges as Bausch Health Appears on the Brink of Bankruptcy
July 24, 2024
Although Bausch Health has denied rumors that it’s on the cusp of bankruptcy, BHC stock is nevertheless suffering from skepticism.
Via
InvestorPlace
Topics
Bankruptcy
Exposures
Financial
Legal
Why Bausch health Shares Are Falling Today
July 24, 2024
Bausch Health Companies Inc. (NYSE: BHC) is experiencing a sharp decline in its stock price Wednesday. The drop was triggered by a report suggesting the company is negotiating a potential prepackaged...
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
Performance
YTD
-23.01%
-23.01%
1 Month
-11.78%
-11.78%
3 Month
-31.23%
-31.23%
6 Month
-26.77%
-26.77%
1 Year
-36.00%
-36.00%
More News
Read More
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 24, 2024
Via
Benzinga
Bausch Health Responds to Market Rumors
July 24, 2024
Via
ACCESSWIRE
Bausch Health Welcomes Two New Members to the Executive Leadership Team
July 19, 2024
Via
ACCESSWIRE
Stocks Plummet After Tech Earnings, Manufacturing Data
July 24, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024
July 11, 2024
Via
ACCESSWIRE
Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
June 20, 2024
Via
ACCESSWIRE
Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences
June 14, 2024
Via
ACCESSWIRE
Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults
May 23, 2024
Via
ACCESSWIRE
Bausch Health Announces 2024 Annual Meeting of Shareholder Results
May 15, 2024
Via
ACCESSWIRE
Why Bausch Health Companies Shares Are Falling After Q1 Results
May 02, 2024
Via
Benzinga
Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024
May 17, 2024
Via
ACCESSWIRE
Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
May 14, 2024
Via
ACCESSWIRE
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
May 09, 2024
Via
ACCESSWIRE
Why Bausch Health Companies Stock Dived by More Than 7% Today
May 02, 2024
Via
The Motley Fool
BHC Stock Earnings: Bausch Health Companies Misses EPS, Misses Revenue for Q1 2024
May 02, 2024
Via
InvestorPlace
Bausch Health Announces First Quarter 2024 Results
May 02, 2024
Via
ACCESSWIRE
Bausch Health to Announce First-Quarter 2024 Results on May 2
April 11, 2024
Via
ACCESSWIRE
Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
April 11, 2024
Via
ACCESSWIRE
Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
April 11, 2024
Via
ACCESSWIRE
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
April 05, 2024
Via
ACCESSWIRE
Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults
April 03, 2024
Via
ACCESSWIRE
Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations
April 02, 2024
Via
ACCESSWIRE
Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma
March 06, 2024
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.